한글목차

세계의 다운스트림 프로세스 시장 규모는 2024년부터 2030년까지 CAGR 13.2%로 성장하여 2030년까지 약 536억 달러에 달할 것으로 예측됩니다. 이 시장의 주요 성장 촉진요인은 바이오의약품 부문의 연구개발비 성장해 바이오의약품 수요 확대, 멸균 을 위한 막 여과 이용 확대, 백신이나 바이오의약품 제조의 농축 기술 의의 등입니다. 바이오의약품 제조업체와 제조수탁기관 시장의 기회에 의해 세계의 다운스트림 프로세스 시장 전망은 유망합니다.

다운스트림 프로세스 시장 인사이트

Lucintel은 일류 제품 제조를 향한 다운스트림 정제 기술 진보에 의해 백신 제조가 예측기간 동안 최대 부문으로 남을 것으로 예측하고 있습니다.

이 시장 중에서는 고령자층 사이에서 바이오의약품에 대한 요구가 높아지고 있어, 바이오의약품 제조업체가 최대 부문으로 남을 것으로 생각됩니다.

아시아태평양은 정부 지원 증가, 연구개발 인프라 성숙화, 전문 지식과 학술적 성과 레벨 향상에 의해 예측기간 동안 가장 높은 성장이 전망됩니다.

자주 묻는 질문

Q1. 시장 규모는?

A1. 세계의 다운스트림 프로세스 시장은 2030년까지 약 536억 달러에 달할 것으로 예상됩니다.

Q2. 시장 성장 예측은?

A2. 세계의 다운스트림 프로세스 시장은 2024년부터 2030년까지 CAGR 13.2%로 성장할 것으로 예측됩니다.

Q3. 시장의 성장에 영향을 미치는 주요 성장 촉진요인은?

A3. 이 시장의 주요 성장 촉진요인은 바이오의약품 부문의 연구개발비 성장해 바이오의약품 수요 확대, 멸균 을 위한 막 여과 이용 확대, 백신이나 바이오의약품 제조의 농축 기술의 중요성입니다.

Q4. 시장의 주요 부문은?

A4. 다운스트림 프로세스 시장의 미래는 바이오의약품 제조업체와 제조수탁기관 시장에 기회가 있어 유망이라고 생각됩니다.

Q5. 시장의 주요 기업은?

A5. 주요 다운스트림 프로세스 기업은 다음과 같습니다.

• Thermo Fisher Scientific
• GE Healthcare
• Sartorius Stedim Biotech
• Merck Millipore
• Danaher
• 3M
• Boehringer Ingelheim
• Lonza
• Eppendorf
• Finesse Solutions

Q6. 향후 최대가 되는 시장 부문은?

A6. Lucintel은 일류 제품 제조를 위한 다운스트림 정제 기술 진보에 의해 백신 제조가 예측기간 동안 최대 부문으로 남을 것으로 예측하고 있습니다.

Q7. 시장에서 향후 5년 동안 최대가 될 것으로 예상되는 지역은?

A7. 아시아태평양은 정부 지원 증가, 연구개발 인프라 성숙화, 전문 지식과 학술적 성과 레벨 향상에 의해 예측기간 동안 가장 높은 성장이 전망됩니다.

Q8. 보고서 커스터마이징이 가능?

A8. 네, Lucintel은 추가 비용 없이 10% 커스터마이징을 제공합니다.

목차

제1장 주요 요약

제2장 세계의 다운스트림 프로세스 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 업계 성장 촉진요인과 과제

제3장 시장 동향과 예측 분석 : 2018-2030년

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 다운스트림 프로세스 시장 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 다운스트림 프로세스 시장 : 기술별
  • 정제
  • 고체-액체 분리
  • 정화/농축
• 세계의 다운스트림 프로세스 시장 : 제품별
  • 크로마토그래피 컬럼·수지
  • 필터
  • 막흡착제
  • 일회용 제품
  • 기타
• 세계의 다운스트림 프로세스 시장 : 용도별
  • 단클론항체 생산
  • 백신 생산
  • 인슐린 생산
  • 면역글로불린 생산
  • 에리스로포이에틴 생산
  • 기타
• 세계의 다운스트림 프로세스 시장 : 최종 이용 산업별
  • 바이오의약품 제조업체
  • 수탁제조기관
  • 기타

제4장 시장 동향과 예측 분석 : 지역별(2018-2030년)

• 세계의 다운스트림 프로세스 시장 : 지역별
• 북미
• 유럽
• 아시아태평양
• 기타 지역

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영상 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 기술별
  • 제품별
  • 용도별
  • 최종 이용 산업별
  • 지역별
• 세계의 다운스트림 프로세스 시장 최신 동향
• 전략적 분석
  • 신제품 개발
  • 세계의 다운스트림 프로세스 시장 능력 확대
  • 세계의 다운스트림 프로세스 시장 합병, 인수, 합작투자
  • 인증과 라이선싱

제7장 유력 기업의 기업 개요

• Thermo Fisher Scientific
• GE Healthcare
• Sartorius Stedim Biotech
• Merck Millipore
• Danaher
• 3M
• Boehringer Ingelheim
• Lonza
• Eppendorf
• Finesse Solutions

영문목차

Downstream Processing Trends and Forecast

The future of the global downstream processing market looks promising with opportunities in the biopharmaceutical manufacturers and contract manufacturing organizations markets. The global downstream processing market is expected to reach an estimated $53.6 billion by 2030 with a CAGR of 13.2% from 2024 to 2030. The major drivers for this market are growth of research and development spending in the biopharmaceutical sector, growing demand for biopharmaceuticals, and growing use of membrane filtration for sterilizing and the significance of concentration techniques for the manufacturing of vaccines and biopharmaceuticals.

A more than 150-page report is developed to help in your business decisions.

Downstream Processing by Segment

The study includes a forecast for the global downstream processing by technique, product, application, end use industry, and region.

Downstream Processing Market by Technique [Shipment Analysis by Value from 2018 to 2030]:

• Purification
• Solid-Liquid Separation
• Clarification/Concentration

Downstream Processing Market by Product [Shipment Analysis by Value from 2018 to 2030]:

• Chromatography Columns & Resins
• Filters
• Membrane Adsorbers
• Single-Use Products
• Others

Downstream Processing Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Monoclonal Antibody Production
• Vaccine Production
• Insulin Production
• Immunoglobulin Production
• Erythropoietin Production
• Others

Downstream Processing Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

• Biopharmaceutical Manufacturers
• Contract Manufacturing Organizations
• Otherss

Downstream Processing Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Downstream Processing Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies downstream processing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the downstream processing companies profiled in this report include-

• Thermo Fisher Scientific
• GE Healthcare
• Sartorius Stedim Biotech
• Merck Millipore
• Danaher
• 3M
• Boehringer Ingelheim
• Lonza
• Eppendorf
• Finesse Solutions

Downstream Processing Market Insights

Lucintel forecasts that vaccine production will remain the largest segment over the forecast period due to advancements in downstream purification technology for the production of top-tier products.

Within this market, biopharmaceutical manufacturers will remain the largest segment due to rising need for biopharmaceuticals among the elderly demographic.

APAC is expected to witness highest growth over the forecast period due to rising governmental backing, the maturation of R&D infrastructure, and the increasing level of expertise and academic achievements.

Features of the Global Downstream Processing Market

Market Size Estimates: Downstream processing market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Downstream processing market size by various segments, such as by technique, product, application, end use industry, and region in terms of value ($B).

Regional Analysis: Downstream processing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different technique, product, application, end use industry, and regions for the downstream processing market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the downstream processing market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the downstream processing market size?

Answer: The global downstream processing market is expected to reach an estimated $53.6 billion by 2030.

Q2. What is the growth forecast for downstream processing market?

Answer: The global downstream processing market is expected to grow with a CAGR of 13.2% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the downstream processing market?

Answer: The major drivers for this market are growth of research and development spending in the biopharmaceutical sector, growing demand for biopharmaceuticals, and growing use of membrane filtration for sterilizing and the significance of concentration techniques for the manufacturing of vaccines and biopharmaceuticals.

Q4. What are the major segments for downstream processing market?

Answer: The future of the downstream processing market looks promising with opportunities in the biopharmaceutical manufacturers and contract manufacturing organizations markets.

Q5. Who are the key downstream processing market companies?

Answer: Some of the key downstream processing companies are as follows.

• Thermo Fisher Scientific
• GE Healthcare
• Sartorius Stedim Biotech
• Merck Millipore
• Danaher
• 3M
• Boehringer Ingelheim
• Lonza
• Eppendorf
• Finesse Solutions

Q6. Which downstream processing market segment will be the largest in future?

Answer: Lucintel forecasts that vaccine production will remain the largest segment over the forecast period due to advancements in downstream purification technology for the production of top-tier products.

Q7. In downstream processing market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to rising governmental backing, the maturation of R&D infrastructure, and the increasing level of expertise and academic achievements.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the downstream processing market by technique (purification, solid-liquid separation, and clarification/concentration), product (chromatography columns & resins, filters, membrane adsorbers, single-use products, and others), application (monoclonal antibody production, vaccine production, insulin production, immunoglobulin production, erythropoietin production, and others), end use industry (biopharmaceutical manufacturers, contract manufacturing organizations, and otherss), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Downstream Processing Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Downstream Processing Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Downstream Processing Market by Technique
  • 3.3.1: Purification
  • 3.3.2: Solid-Liquid Separation
  • 3.3.3: Clarification/Concentration
• 3.4: Global Downstream Processing Market by Product
  • 3.4.1: Chromatography Columns & Resins
  • 3.4.2: Filters
  • 3.4.3: Membrane Adsorbers
  • 3.4.4: Single-Use Products
  • 3.4.5: Others
• 3.5: Global Downstream Processing Market by Application
  • 3.5.1: Monoclonal Antibody Production
  • 3.5.2: Vaccine Production
  • 3.5.3: Insulin Production
  • 3.5.4: Immunoglobulin Production
  • 3.5.5: Erythropoietin Production
  • 3.5.6: Others
• 3.6: Global Downstream Processing Market by End Use Industry
  • 3.6.1: Biopharmaceutical Manufacturers
  • 3.6.2: Contract Manufacturing Organizations
  • 3.6.3: Otherss

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Downstream Processing Market by Region
• 4.2: North American Downstream Processing Market
  • 4.2.2: North American Downstream Processing Market by End Use Industry: Biopharmaceutical Manufacturers, Contract Manufacturing Organizations, and Otherss
• 4.3: European Downstream Processing Market
  • 4.3.1: European Downstream Processing Market by Application: Monoclonal Antibody Production, Vaccine Production, Insulin Production, Immunoglobulin Production, Erythropoietin Production, and Others
  • 4.3.2: European Downstream Processing Market by End Use Industry: Biopharmaceutical Manufacturers, Contract Manufacturing Organizations, and Otherss
• 4.4: APAC Downstream Processing Market
  • 4.4.1: APAC Downstream Processing Market by Application: Monoclonal Antibody Production, Vaccine Production, Insulin Production, Immunoglobulin Production, Erythropoietin Production, and Others
  • 4.4.2: APAC Downstream Processing Market by End Use Industry: Biopharmaceutical Manufacturers, Contract Manufacturing Organizations, and Otherss
• 4.5: ROW Downstream Processing Market
  • 4.5.1: ROW Downstream Processing Market by Application: Monoclonal Antibody Production, Vaccine Production, Insulin Production, Immunoglobulin Production, Erythropoietin Production, and Others
  • 4.5.2: ROW Downstream Processing Market by End Use Industry: Biopharmaceutical Manufacturers, Contract Manufacturing Organizations, and Otherss

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Downstream Processing Market by Technique
  • 6.1.2: Growth Opportunities for the Global Downstream Processing Market by Product
  • 6.1.3: Growth Opportunities for the Global Downstream Processing Market by Application
  • 6.1.4: Growth Opportunities for the Global Downstream Processing Market by End Use Industry
  • 6.1.5: Growth Opportunities for the Global Downstream Processing Market by Region
• 6.2: Emerging Trends in the Global Downstream Processing Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Downstream Processing Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Downstream Processing Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Thermo Fisher Scientific
• 7.2: GE Healthcare
• 7.3: Sartorius Stedim Biotech
• 7.4: Merck Millipore
• 7.5: Danaher
• 7.6: 3M
• 7.7: Boehringer Ingelheim
• 7.8: Lonza
• 7.9: Eppendorf
• 7.10: Finesse Solutions